New test could better match ovarian cancer patients to Life-Extending drugs
NCT ID NCT06152731
Summary
This study is comparing two different lab tests to see which one better identifies ovarian cancer patients who are likely to respond well to chemotherapy and may benefit from a follow-up targeted drug. It involves 88 women newly diagnosed with advanced ovarian cancer. The goal is to improve how doctors choose the right treatment for each patient based on their tumor's genetic features.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Francois Baclesse
RECRUITINGCaen, France
Contact
-
Centre Henri Becquerel
RECRUITINGRouen, France
Contact
-
Centre Oscar Lambret
RECRUITINGLille, France
Contact
-
Chu Amiens
NOT_YET_RECRUITINGAmiens, France
Contact
Conditions
Explore the condition pages connected to this study.